ADJUVANT TREATMENT WITH BIPHOSPONATES IN COMPLEX THERAPY OF PAPILLARY THYROID CANCER BONE METASTASES

ADJUVANT TREATMENT WITH BIPHOSPONATES IN COMPLEX THERAPY OF PAPILLARY THYROID CANCER BONE METASTASES

Distant metastasis of thyroid cancer are founded in 10% of all metastases. Bone metastases are founded in 23% of distant metastasis. Complications associated with metastatic skeletal involvement often lead to a deterioration in the overall condition and a decrease in the quality of life of patients....

Full description

Bibliographic Details
Main Authors:	A. D. Kaprin, A. P. Polyakov, P. O. Rumiantsev, K. S. Nizegorodova, M. V. Degtiarev, P. A. Nikiforovich, M. V. Ratushnyy, O. V. Matorin, M. M. Filushin, I. V. Rebrikova, A. L. Sugaipov, A. V. Mordovskiy
Format:	Article
Language:	Russian
Published:	QUASAR, LLC 2017-09-01
Series:	Issledovaniâ i Praktika v Medicine
Subjects:	болевой синдром золедроновая кислота рак щитовидной железы костная резорбция костные метастазы качество жизни
Online Access:	https://www.rpmj.ru/rpmj/article/view/204

Similar Items

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
by: T. Yu. Semiglazova, et al.
Published: (2014-07-01)

First report of observation trial about impact of bisphosphonate`s treatment to the quality of life breast cancer patient with bone metastases
by: O. V. Zelenova, et al.
Published: (2014-07-01)

DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
by: O. I. Apolikhin, et al.
Published: (2016-01-01)

Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report)
by: E. E. Stanyakina, et al.
Published: (2019-07-01)

EFFICACY AND TOLERABILITY OF GENERIC ZOLEDRONIC ACID 5 MG (REZOCLASTIN PS) IN THE TREATMENT OF OSTEOPOROSIS: A RETROSPECTIVE ANALYSIS OF CLINICAL EXPERIENCE WITH THE DRUG IN RUSSIA
by: L A Marchenkova, et al.
Published: (2014-12-01)

Massive osteolysis - gorham-stout syndrome
by: E. N. Otteva, et al.
Published: (2011-04-01)

SURGICAL TREATMENT OF DISTROPHICAL BONE KISTS BY TITANIUM NIKELID POROUS MATERIALS IN CHILDREN
by: G. V. Slizovskiy, et al.
Published: (2015-04-01)

Current opportunities of comprehensive therapy for bone metastases from thyroid cancer
by: A. P. Polyakov, et al.
Published: (2020-11-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
by: N. V. Toroptsova, et al.
Published: (2021-10-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
by: S Yu Vorotnikova, et al.
Published: (2016-12-01)

OSTEOCALCIN DINAMIC OF DISTROPHICAL BONE KISTS BY TITANIUM NIKELID POROUS MATERIALS IMPLANTATION IN CHILDREN
by: I. I. Kuzhelivsky, et al.
Published: (2015-10-01)

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
by: A. D. Petrova, et al.
Published: (2014-07-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid
by: N. V. Toroptsova, et al.
Published: (2022-05-01)

TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH NITROGEN CONTAINING BISPHOSPHONATES, EARLY SIDE EFFECTS AND THEIR PREVENTION
by: O V Yakushevskaya, et al.
Published: (2013-12-01)

BISPHOSPHONATES IN PROPHYLAXIS OF SKELETAL-RELATED ADVERSE EVENTS IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: E. Yu. Safronova, et al.
Published: (2016-06-01)

MRI TECHNIQUE OF DYNAMIC CONTRAST ENHANCEMENT APPLIED TO THE DIAGNOSIS AND MONITORING OF CHEMO-RADIATION TREATMENT OF SECONDARY BONE LESIONS
by: N. I. Sergeev
Published: (2016-02-01)

Target approach to treating osseous system pathology
by: M. B. Stenina, et al.
Published: (2014-08-01)

THE POSSIBILITY OF TREATING PATIENTS WITH GASTRIC CANCER WITH METASTASES TO THE BONES OF THE SKELETON
by: N. V. Rasulova, et al.
Published: (2017-02-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

A RARE CASE OF THYROID CANCER METASTASIS TO PARAPHARYNGEAL LYMPH NODES
by: V. Zh. Brzhezovsky, et al.
Published: (2015-04-01)

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER
by: A. P. Polyakov, et al.
Published: (2017-04-01)

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
by: O V Yakushevskaya, et al.
Published: (2012-08-01)

Prevention of bone metastases in breast cancer
by: L. M. Kogonia
Published: (2014-08-01)

PATOGENETIChESKIE OSNOVY RAZVITIYa OSTROY FAZY OTVETA NA VNUTRIVENNOE VVEDENIE AZOTSODERZhAShchIKh BISFOSFONATOV
by: O V YaKUShEVSKAYa, et al.
Published: (2014-12-01)

Local and generalized bone loss in rheumatoid arthritis
by: P. S. Kovalenko, et al.
Published: (2021-10-01)

Preoperative detection of papillary and medullary thyroid cancer metastases in the lymph nodes of the neck lateral cellular tissue using a molecular classifier
by: S. E. Titov, et al.
Published: (2021-01-01)

Comparative effectiveness of intra-articular administration of different drugs of hyaluronic acid with various physico-chemical properties in knee osteoarthritis
by: E. A. Belyaeva, et al.
Published: (2021-12-01)

Ultrasound diagnosis of cervical levels II–IV lymph node metastasis in patients with first diagnosed papillary thyroid cancer
by: V. S. Parshin, et al.
Published: (2020-02-01)

ANALYSIS OF RELAPSE RATE AND METASTASES OF HIGH DIFFERENTIATED THYROID CANCER
by: E. V. Savenok, et al.
Published: (2015-04-01)

CURRENT CAPABILITIES AND PROSPECTS OF CHEMORADIOTHERAPY FOR MEDULLARY THYROID CANCER (A LITERATURE REVIEW)
by: I. S. Pimonova, et al.
Published: (2017-11-01)

Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
by: А. М. Mudunov, et al.
Published: (2019-10-01)

Practical recommendations for the prevention of surgical complications related to the procedure of the interalveolar osteotomy
by: S. G. Ananyan, et al.
Published: (2015-06-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Osnovnye aspekty primeneniya bisfosfonatov v onkologii
by: A P Kondrat'eva
Published: (2005-06-01)

Morphological assessment of the regeneratory function of the tooth root cement with destructive periodontitis
by: V. V. Glinkin, et al.
Published: (2022-10-01)

The clinical significance of the features of the morphological study and immunohistochemical determination of pancytokeratin in the lymph nodes of the central zone in papillary thyroid cancer
by: D. A. Galushko, et al.
Published: (2022-12-01)

Treatment of destructive periodontitis with combined root resorption. Clinical case
by: V. V. Glinkin, et al.
Published: (2022-07-01)

СRANIAL AND INTRACRANIAL METASTASES OF THYROID CANCER
by: V. B. Karakhan, et al.
Published: (2015-04-01)

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER
by: R. A. Murashko, et al.
Published: (2017-11-01)